AIA: ARCHITECTS OF THE COUNTRY, UNITE!

Architects, via the venerable AIA, are being asked to call their Senators ASAP.

From their membership wide e-mail on the morning of 3/19:

“URGENT: AIA member call to action for R&D Tax bill

Two urgent dates concerning AIA members are approaching. The first is March 22nd when the Congress must pass a second round of appropriations bills to fund the government and avoid a partial government shutdown. The second is April 15th when federal income tax filings are due.  

These two dates are important for action on HR 7024, the Tax Relief for American Families and Workers Act of 2024. This bill can either be added to the government funding bills being considered this week or brought up for a stand-alone vote in the United States Senate. Either result will head to the President, become law, and the IRS can begin to enact its provisions to benefit architects.  

AIA National is organizing a call-in campaign to urge the Senate to move forward and pass the bill without further delay. On Wednesday, March 20th, we are asking you to call your Senators and let them know you support the R&D and LIHTC provisions in the bill, briefly explain why these provisions are important to you, ask them to urge their leadership to bring the bill up for a vote, and ask them to vote in favor of the bill without amendments.”

The AIA Federal Affairs Team continues: “There are over 19,000 small, medium, and large architecture firms throughout the US. These businesses employ more than 200,000 individuals. Architects have a professional responsibility to protect the health, safety, and welfare of the public. Investments in research and development are central to the day-to-day work of architects and drive local, regional, and national economies. AIA supports business-friendly tax policies that encourage investment in research and development, incentivize private-sector affordable housing, and ensure tax parity between large and small businesses. If Congress does not enact the Tax Relief for American Families and Workers Act of 2024 (HR 7024), architecture firms of all sizes will face undue restrictions on their ability to innovate, grow, and attract new talent.  [***] The 2017 Tax Cuts and Jobs Act (TCJA) requires businesses to amortize R&D costs over 5 or 15 years for domestic and international expenses, respectively. Prior to 2022, these expenses were fully deducted in the year they were incurred. Amortization adversely impacts businesses by increasing costs, negatively impacting employee retention, and new job creation, and limiting future investment in research and development. AIA supports HR 7024 changes that allow tax deductions of R&D expenses in the year incurred.”

The AIA knows these 174 provisions are a doozy, and outlined key aspects for members on its website (PDF here: AIA R&D Changes Overview (Credit/174) ) and stated, in line with Blackland’s stance, that: “It is important to note that the changes to Section 174 requiring amortization of R&D costs apply whether or not the filer also claims an R&D tax credit.

Architects— call your Senators now. And then call us for R&D services.

House of Representatives Passes Delay of 174 Mandatory Amortization Provision

Yesterday the US House of Representatives passed a franken-bill to address a grab bag of tax issues. The $78 billion tax bill was argued over for a while, unlike some other expensive bills. (You know the ones.) But 5 or 6 or 7 years after tax experts first said “hey, this 174 thing is a problem that needs to be corrected,” one half of the Congress has done it! Now it needs to go to the Senate for more soundbites and partisan wrangling, and finally to be signed by whoever is signing bills into law in the White House. I haven’t seen Schoolhouse Rock in years, so I’m winging it here.

As the legislation stands:

  • Delays the mandatory capitalization of R&D expenditures until tax year 2026

  • has some other stuff that isn’t R&D related*

So, where do you stand if you’re in the technical jobs/ R&D space? With a very temporary reprieve from dealing with phantom net income issues and a LIMITED window to get ahead on cash flow, if the legislation makes it to the finish line. I expect to see more political wrangling that will be hitting late 2025, early 2026, or maybe 2028 if the next Congress waits until well after the impacts started happening to taxpayers.

If you’re not already thinking about calling us, and you do anything “technical” in your work— engineering, architecture, biology, sciences, computer programming, software development, manufacturing— maybe give it a ponder.

The vote was passed by an obvious majority voice vote, and then House TX District 21 Rep. Chip Roy** asked for the tally. At the end, 357 yays to 70 nays, with 169 Republicans voting yay and 188 Democrats voting yay, and the nays were 47 and 23 respectively by party. 5 Congress members were maybe too busy with other things and didn’t vote.

Here in Texas, the No votes were:

  • TX 21- Chip Roy - R

  • TX 37- Lloyd Doggett - D

  • TX 26- Burgess - R

  • TX 35 - Casar- D

  • TX 29- Garcia - D

  • TX 5 - Gooden - R

  • TX 27- Cloud- R

With Roy, Doggett, Casar, and Cloud all voting nay in a bipartisan way, our local R&D clients have a long way to go to get our representation that understands how bad the 174 provision is. Or maybe they understand (maybe Roy does now?) but it still wasn’t enough for a yay vote because of the other parts they did not like. We did notice Rep. Roy went from some spicy comments about whores (sic) for corporations to a more measure approach on the R&D expensing issue.

My free commentary, if anyone is foolish enough to still be reading: The R&D provisions being called corporate welfare is insane. Most R&D expenditures under the tax code are employee wages, and since when is it corporate welfare to be allowed to expense an operating cost like wages? It completely distorts taxable net income if you can only deduct a small portion of employee wages, or only a small portion of supply expenditures used that year, or only a small portion of your contractors’ invoices. Then you end up with a huge net income on paper, but only a normal net income in your bank account, and a tax bill that matches the former, not the latter. But who cares about understanding actual tax math and 40 years of case law? Not good for soundbites. Not good for Super Bowl small talk, either. Only good for Blackland staff and our accounting friends!

We will post updates on whatever happens to the 174 delay as the legislation moves forward, or doesn’t.

-Jimmy

*Child Tax Credit, Bonus Depreciation, Taiwan stuff, disaster tax stuff, ERTC fraud enforcement, and something about low income housing.

** February 2nd update: We’ve been in contact with Rep. Roy’s office. They seem to be willing to learn more about the mechanics and case law of R&D provisions, and we do acknowledge that Rep. Roy has voted no because of one of those other parts of the bill. I hope that Rep. Roy and others can advance a 174 specific fix sometime between now and 2026.

FREE CPE for Texas CPAs- New Braunfels, San Marcos, San Antonio, Austin, Round Rock, Seguin, Bulverde, Boerne, etc.

After compiling so much research, and so much material, it was fairly straight-forward to put together an in-depth CPE for Texas CPAs. We are now officially registered with the Texas State Board of Public Accountancy and are offering a free CPE course. (Official disclaimer: “We are registered with the Texas State Board of Public Accountancy as a CPE sponsor. This registration does not constitute an endorsement by the board as to the quality of our CPE program.'")

What does this mean? The implications of §174 are both severe and not well-known. Call us. Email us. Text us. We will come to YOUR office, at a convenient time, to deliver a Live Classroom Instruction course for YOU and all your CPAs. FREE OF CHARGE. 50+ instructional minutes and 1.0 credit of CPE. Instructors with combined 21 years of experience with R&D issues. Plus maybe a joke or two, depends on if I’ve had enough coffee.

The course is titled with the state board as “2023 Code, Reg, & Case Updates- R&D Issues”, which means we will be covering the basics of the R&D Credit, the R&E Tax, Section 41, Section 174, related regulations, and applicable case law to bring your office up to speed on the latest and (not-so) greatest about the world of R&D expenditure treatment in the US Tax Code.

Call us or text us 830-420-6890. Tell your CPA friends. We will travel the whole region: New Braunfels, San Marcos, San Antonio, Austin, Kyle, Seguin, Round Rock, Georgetown, Boerne, Fredericksburg, Johnson City, Bastrop, Lockhart, Luling, Schulenburg, La Grange even!

The Sweeping Implications of I.R.C. §174 and Notice 2023-63

https://www.irs.gov/pub/irs-drop/n-23-63.pdf

It’s bad. Bombastic? No, it’s truthful. I take this IRS notice as an acknowledgment that our analysis of 162 vs 174 vs 41 had merit, as the IRS’s proposed regulation explicitly clarifies that 174 takes precedent over 162, as (respect due to the Treasury lawyers and the argument) they’ve applied Snow v. Commissioner with the new 174 language to assert that 174 is applicable to all taxpayers incurring R&E costs “in connection with” a trade or business, and this is a broader and wider net than “carrying on” a trade or business, therefore 174 is MANDATORY. The notice is prospective, so kudos to clients who listened to us earlier in the year, since it appears that the IRS is conceding it does not intend to revisit decisions made in the utter dark with no Treasury guidance earlier in the year.

Under the pending regulations, the IRS will now potentially look at the expenditures and activities of any taxpayer and determine if costs a business put under 162 rightfully belong under 174 instead. As under our previous analysis, Section 41 R&D tax credits DO NOT TRIGGER Section 174. The government is making clear its intention that the taxpayer must categorize costs into 174 regardless of whether the taxpayer is taking a §41 tax credit.

Businesses be warned: if your activities and expenditures are eligible for §41 tax credits, they are required to be treated under §174 (prospectively applied, according to the government for all tax years ending September 8, 2023 or later). This begs an odd scenario, where we used to call on prospective clients to let them know they could be eligible to claim an R&D tax credit under §41… Now the IRS might be auditing businesses to let them know the same thing, because §174 treatment is required for eligible R&E costs. We don’t want to sell on doom and fear, but to be honest with yall, I am worried for businesses now. Are your §174 expenditures properly categorized? If we called you in the past and you declined to pursue a §41 tax credit, would you find out in an IRS audit that §174 is mandatory, even if claiming a §41 tax credit is optional? The way the new regulation is positioned, yes, I certainly think this is a real possibility. Imagine the insanity of getting audited, and the IRS agent essentially runs an R&D/R&E study analysis on your company to determine how many dollars have been deducted under §162 inappropriately. You’d get a bigger tax bill on the spot, and the IRS isn’t going to claim the §41 R&D tax credit on your behalf as far as I know.

We will be adding §174 R&E Expenditure studies to our service line for the 2024 tax season, assuming this Trump era tax law isn’t fixed before the end of the year. Congress has been talking about fixing it for a long time with no action. The American Families and Jobs Act to Support American Businesses (HR 3936, HR 3937, & HR3938 combined) was ceremoniously introduced in June, but went about as far as a car on blocks. Also waiting around doing nothing even before AFAJASAB showed up have been Senate Bills S.866 and S.4822 and House Bill HR 2673, each with an ever-growing roster of bipartisan sponsors. Alas, Congress is all hat, no cattle. But it’s a bipartisan hat, according to their tweets and press releases. So there’s that.

If you’re reading this, it might be time to finally give your Congressman a call. Tell them how Congress needs to fix a boring tax law ASAP. If it’s not fixed, I encourage you to ask your CPA about your §174 expenditures. You and your CPA should give us a call, and let’s talk about a §174 Study and an R&D Tax Credit Study, since it appears that in the near future a can of worms could be opened if you are audited and haven’t addressed your §174 costs appropriately. The §174 costs will increase your current year tax bill as well, since mathematically it takes years to return to a baseline tax bill.

The US government is embarking on a strange quest to stifle American technical jobs by being the only OECD country to disallow single-year deductions of R&E expenses. It’s a cash flow disaster for start-ups, software companies, technical firm, and scientific companies who now will be forced to pay income tax on 80-90% of these R&E expenses in the first year, as if the expenses were actual revenue. Businesses paid an expense, and the government is hitting them with the Reverse Uno card and saying no, that’s income.

In summary, as of now, our previous analysis should not be used moving forward. We join the rest of the accounting world in treating §174 as mandatory. The remainder of the notice provides guidance on nuances and mechanical aspects of §174, but that stuff is only interesting to CPAs and tax lawyers. Disregard §174 in favor of §162 at your own risk, the IRS may disagree with your expense treatment and run an R&E study on your company.

The Widespread Concern About Section 174’s Changes is Misleading

UPDATE UPDATE UPDATE: READ HERE

As of September 8, 2023, the information below is outdated.

Since the Tax Cuts and Jobs Act of 2017, many voices have raised concerns over the treatment of expenses under section 174. I will be the first to admit that in our shop, we wondered about it and had heard the provision would surely be re-written because of the dire consequences to so many taxpayers. We did not raise an alarm, however, because we wanted to know more. For 99% of our clients, we would like to reassure you that it is a non-issue for you. If you are a software development client, we need to talk—unfortunately, your situations are less clear currently.

First, a little background on what we are talking about here: deductions, amortized expenses, capitalized expenses, and credits. Income tax is the tax levied on income. Income is gross income or net income. Net income is the gross income minus the expenditures you can subtract from the amount you will be taxed on. These expenditures that you subtract from income come in two main forms—those that are deducted (100% or partially) and those that were amortized (also called capitalized). The government’s default position is that expenditures are capitalized, which means assigned to a capital account (a log of what you’ve spent or invested in your business). The capital account, at its most basic, will lower your tax liability when the business is sold—the sale price minus the amount tracked in the capital account equals the amount that a tax rate will be applied to (this is a capital gain tax). Some capital accounts are used before the final sale of the business. When the expenditure is broken up over multiple years (typically a 5, 10, 15, or 20 year schedule), this is amortization. When an expense is deducted, it can be a partial deduction (for example, 50% deduction of certain business meals & entertainment expenditures) or it can be 100% of the expense (for example, rent, utilities, phone service, employee wages). Once the tax rate is applied to the net income, the resulting amount is called your tax liability. If you have a tax credit, the amount of the credit is then subtracted from the tax liability. This final figure is ultimately your tax bill.

The standard business deductions are found under section 162 of the Internal Revenue Code. The provision allows on-going businesses to deduct those normal expenditures from their overall revenue to determine their taxable net income. Section 174 was passed in 1954 and specifically allowed less-established business ventures to deduct specified expenditures, namely a defined set of research and experimentation expenditures. Section 41, passed in 1981, governs the R&D Tax Credit. Section 41 uses expenditures, which could also be defined under section 174’s expenditures, but also adds additional restrictions on what section 41 qualifying expenditures are. It is important to understand that section 41 expenditures are not section 174 expenditures, even though there is substantial overlap in defining the expenditures. Formerly, section 174 allowed the taxpayer to choose between a deduction (100% of those costs can be subtracted from any income) or to be amortized (in this case, spread out over 5 years, 1/5 of the amount deducted each year). With the resent changes, those using section 174 only have the latter option to amortize.

To explore the distinction between section 41 and section 174, I will start with a distant memory from my first green days involved in R&D Tax Credit work: we read section 41 and glossed over the part in section 41 that referenced section 174. I asked my supervisor something along the lines of: if we work with a new client, and they have previously never used section 174 for these expenses, and they have been using “normal deductions” (as you would call most everything treated under section 162), do these expenses get recategorized as 174 expenses in order to make it into the credit’s calculation? The answer was, more or less, to move on with the work day as it was a moot question, because section 174 and section 162 allowed the taxpayer to treat them the same and so virtually all taxpayers, since the RTC passed in 1981, had never had to make the call or even contemplate the mechanics of how expenses “enter” into section 41 calculations—assuming the expenses otherwise qualified under the provisions of section 41. Never to my knowledge, has a company been required to conduct a change in accounting method to convert expenses treated under section 162 into expenses treated under section 174 to claim the R&D tax credit. Consistency in methodology and treatment, as well, would indicate to some extent that section 162 expenses remained as such, but were also otherwise qualified as section 41 eligible costs towards the R&D credit calculation.

Fast forward to the closing of tax year 2022, with the amended section 174 really being a point of focus for many CPAs and taxpayers. At Blackland Tax, we have been through the text, the regulations, and the case law, and after all of it, one big question remains for those insisting on mandatory conversion of expenses from section 162 treatment to treatment under section 174: Unless it’s software, where is that coming from?

We know section 41 references section 174, but it is not a barrier to use under section 41. It is applied in reference to the definition of the activities in section 174—namely, when expressly written for the first time into the tax code in 1954, it identified certain experimental and research activities that taxpayers may undertake and subsequently deduct, as it said, “in connection with a trade or business” in comparison to section 162’s “carrying on a trade or business”. To put into layman's terms, before 1954, the IRS used to disallow deducting expenses in your garage start-up, or fledgling business, because you were not carrying on a business, you were not an established business… you were perhaps more akin to Professor Brainard developing flubber, rather than Flubber, Inc. with staff developing the next iteration of flubber.

Here is the reference in 26 U.S Code §41:

§41(d)Qualified research defined

For purposes of this section—

(1) In general

The term “qualified research” means research—

(A)

with respect to which expenditures may be treated as specified research or experimental expenditures under section 174

 

The IRC goes on into much more depth defining the nature and scope of activities and exclusions for determining qualified expenses for the R&D credit, but that is what section 41 says about section 174: expenditures which may be treated as R&E expenditures under section 174.

 

At the risk of being too much of a lawyer, and a tax lawyer to boot, “may” means something very different from other words. The expenses that “may” be treated as R&E expenditures under section 174. And it is used in section 41 to help define the types of expenses (like Professor Brainard needed!) that could (formerly) be deducted in connection with a trade or business rather than the carrying on of a trade or business. It is a stricter definition of qualifying expenses (R&E type expenses), but a broader application of which taxpayers are qualified to take these expenses—the taxpayer no longer had to pass the threshold test of being established and carrying on a business, of offering products or services for sale, lease, or license. And so, section 41 leans on and references section 174 for the purposes of defining those expenditures.

 

Maybe taxes are not your thing. Let’s imagine a weird high school biology class—there’s a cell with a membrane, we’ll call it cell 41. Cell 41's membrane is semi-permeable. Two types of proteins can pass through its membrane--- type 174 proteins that come from the 174 gland or type 174 proteins that come from the 162 glands—which makes proteins of varying kinds, including type 174 proteins. Cell 41 does not require 162 glands to change into 174 glands to produce type 174 proteins. The type 174 proteins that the 162 gland produces already fit through the cell 41's membrane.

 

We worked through it using a classic tax law class hypothetical format as follows:

Taxpayer ABC is carrying on a trade or business. ABC decides this year to NOT claim the R&D credit. Why? His well-meaning CPA read in an article that all wages will need to be reclassified as section 174 and amortized over 5 years. Therefore, under the CPA's guidance, the section 41 RTC is not claimed and all the wages are treated under section 162. Are they section 162 expenses or section 174 expenses? Making the obvious choice, they are treated as section 162 expenses, as there is no mandatory language to reclassify expenditures under section 174, when the taxpayer carrying on a trade or business may otherwise treat them under section 162.

 

Taxpayer DEF, too, is carrying on a trade or business. DEF decides to claim the R&D credit. Section 41(d)(1) says "the term qualified research means research (A) with respect to which expenditures MAY be treated as specified research or experimental expenditures under section 174". Expenses in connection with the taxpayer's trade or business treated as section 174 expenses are required to be capitalized under the new law. Expenses incurred in carrying on the trade or business are deductible under section 162. Taxpayer DEF must decide to treat the expenses as section 174 or section 162 expenses. Taxpayer DEF decides to treat them as section 174 and then suffers through the 5-year amortization effects of higher taxes in the beginning years.

 

Meanwhile, taxpayer GHJ is carrying on a trade or business. GHJ decides to claim the R&D credit. Section 41(d)(1) says "the term qualified research means research (A) with respect to which expenditures MAY be treated as specified research or experimental expenditures under section 174". Expenses treated as section 174 are required to be capitalized under the new law. Expenses incurred in carrying on the trade or business are not required to be capitalized under section 162. Taxpayer GHJ must decide to treat the expenses as section 174 or section 162 expenses. Taxpayer GHJ decides to treat the expenses as section 162 expenses and claim the section 41 RTC credit. Taxpayer GHJ is unaffected by the amortization provisions, therefore, so long as taxpayer GHJ elected to treat expenses as section 162 expenses "in carrying on a trade or business", and not section 174 expenses "in connection with a trade or business" (as would be his choice to make, I assume, for R&E activities qualifying for both treatment under section 174 or section 162, in connection with or in carrying on, respectively).

 

The choices above would potentially have huge impacts. As an example, imagine an engineering firm with revenues of $1.5 million dollars and $1 million in engineering wages.  Assuming all the engineering wages met requirements for both section 162 and section 174, if the $1 million in wages is deducted under section 162, then the engineering firm is paying on a taxable income of $500k.  With a 20% tax rate, that puts the regular tax liability (before any credit) for the year at $100k.  If the $1 million in wages is amortized over 5 years under section 174, only $200k of the $1 million in wages can be used to reduce income in the first year leaving a taxable income of $1.3 million.  With a 20% tax rate, that puts the regular tax liability at $260,000. The effect continues, and in year 5, the situation has pseudo-stabilized with 5 years of 1/5th deductions added together, but the tax bills have been larger for 4 years running.

 

The questions for anyone concerned about sweeping changes to the R&D credit are:

1.) Is the average taxpayer carrying on a trade or business required to use section 174 for expenses that may be categorized either as section 174 or section 162 expenses? If so, where is that provision in the code? If the taxpayer used an expense type (let’s say, wages) for a section 41 credit calculation previously, but doesn’t claim it moving forward, does anyone posit that this category of expenses is nonetheless required to be treated under section 174 moving forward?

2.) If the barrier to entry for section 41 is expenditures that "may" be treated as section 174 expenses, where does the code require conversion of section 162 expenses into section 174 expenses prior to utilization for section 41 RTC calculation purposes?

My conclusion, by plain reading of the provisions, is that the taxpayer carrying on a trade or business may treat R&E expenses under section 162, or if they wanted to, under section 174 in connection with a trade or business (the looser standard), and that utilizing the section 41 RTC does not preclude or ban the taxpayer from using section 162 treatment of expenses. The crucial piece is meeting the long-standing and well-established standard of carrying on the trade or business-- the stage of holding themselves out as providing the goods or services they started their business to provide. Only new ventures that fail to meet the threshold test of carrying on their trade or business, or software ventures that are specifically targeted under section 174, would fail to have the option between treatment under section 162 or section 174, and thus be forced to use section 174's treatment of amortizing said R&E expenditures.

For further reading, and in case you think my opinion needs more weight, I highly recommend reading “Changing Research Tax Break Rules Will Harm Fewer Than Predicted” by Rick Kleban, Dainer Reinier, and James Bean on Bloomberg.com Bloomberg Law/Bloomberg Tax blog found here:

https://news.bloomberglaw.com/tax-insights-and-commentary/changing-research-tax-break-rules-will-harm-fewer-than-predicted

 For clients and CPAs with further questions, please contact me directly for more in-depth information regarding this issue. The above is provided for general educational purposes only and you should always seek the advice of a tax professional for your specific questions or for advice. This article is not legal advice or accounting advice specific to any one person.

Cheers,

Jimmy